Optical imaging in breast cancer diagnosis: The next evolution

Journal of Oncology

Volumn , Issue , 2012, Pages

  Herranz, Michel ^a   Ruibal, Alvaro ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENT DYE; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; HEMOGLOBIN; INDOCYANINE GREEN; LIPID; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TETROFOSMIN TC 99M; WATER;

BREAST CANCER; CANCER DIAGNOSIS; FLUORESCENCE IMAGING; INFRARED RADIATION; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICS; POSITRON EMISSION TOMOGRAPHY; REVIEW; ULTRASOUND;

EID: 84871843095     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2012/863747     Document Type: Review

References (61)

1. Garcia M., Jemal A., Ward E. M., Center M. M., Hao Y., Siegel R. L., Thun M. J., Global Cancer Facts & Figures 2007 2007 Atlanta, Ga, USA American Cancer Society
2. American cancer Society,. Statistics for 2004: Cancer facts & figures, 2004, http://www.cancer.org/research/cancerfactsfigures/ cancerfactsfigures/index
3. Feig S. A., Decreased breast cancer mortality through mammographic screening: results of clinical trials. Radiology 1988 167 3 659 665 2-s2.0-0023916542
4. Breast cancer. Early detection and prompt treatment are critical. Mayo Clinic Health Letter 2001 supplement 1-8
5. Jacques S. L., Time resolved propagation of ultrashort laser pulses within turbid tissues. Applied Optics 1989 28 12 2223 2229
6. Kerlikowske K., Barclay J., Grady D., Sickles E. A., Ernster V., Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer. Journal of the National Cancer Institute 1997 89 1 77 82 2-s2.0-0030636730 (Pubitemid 26428081)
7. Homer M. J., Breast imaging: pitfalls, controversies, and some practical thoughts. Radiologic Clinics of North America 1985 23 3 459 472 2-s2.0-0022413512 (Pubitemid 16197445)
8. Wang J., Shih T. T. F., Hsu J. C. Y., Li Y. W., The evaluation of false negative mammography from malignant and benign breast lesions. Clinical Imaging 2000 24 2 96 103 2-s2.0-0033676372 10.1016/S0899-7071(00)00184-4
9. Shapiro S., Strax P., Venet L., Periodic breast cancer screening in reducing mortality from breast cancer. Journal of the American Medical Association 1971 215 11 1777 1785 2-s2.0-0015224462 10.1001/jama.215.11.1777
10. Thurfjell E. L., Lindgren J. A., Breast cancer survival rates with mammographic screening: similar favorable survival rates for women younger and those older than 50 years. Radiology 1996 201 2 421 426 2-s2.0-0029976880 (Pubitemid 26357637)
11. Hendrick R. E., Smith R. A., Rutledge J. H. III, Smart C. R., Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. Journal of the National Cancer Institute Monographs 1997 22 87 92 2-s2.0-0031316208
12. Tabar L., Vitak B., Chen H. H., Yen M. F., Duffy S. W., Smith R. A., Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer 2001 91 9 1724 1731 (Pubitemid 32377958)
13. Boone J. M., Normalized glandular dose (DgN) coefficients for arbitrary x-ray spectra in mammography: computer-fit values of Monte Carlo derived data. Medical Physics 2002 29 5 869 875 2-s2.0-0035999415 10.1118/1.1472499 (Pubitemid 34525916)
14. Hammsterstein G. R., Miller D. W., White D. R., Absorbed radiation dose in mammography. Radiology 1979 130 2 485 491 2-s2.0-0018316082 (Pubitemid 9070569)
15. Kolb T. M., Lichy J., Newhouse J. H., Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 2002 225 1 165 175 2-s2.0-0036787397
16. FDA,. US Public Health Advisory: Update on Magnetic Resonance Imaging (MRI) Contrast Agents Containing Gadolinium and Nephrogenic Fibrosing Dermopathy, 2006, http://www.fda.gov/Cder/Drug/advisory/gadolinium(agents) 20061222.htm
17. Gribbestad I. S., Sitter B., Lundgren S., Krane J., Axelson D., Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy. Anticancer Research 1999 19 3 1737 1746 2-s2.0-0032809945 (Pubitemid 29392730)
18. Yutani K., Shiba E., Kusuoka H., Tatsumi M., Uehara T., Taguchi T., Takai S. I., Nishimura T., Comparison of FDG-PET with MIBI-SPECT in the detection of breast cancer and axillary lymph node metastasis. Journal of Computer Assisted Tomography 2000 24 2 274 280 2-s2.0-0034466373 10.1097/00004728-200003000-00017 (Pubitemid 32206208)
19. Smith M. F., Majewski S., Weisenberger A. G., Kieper D. A., Raylman R. R., Turkington T. G., Analysis of factors affecting positron emission mammography (PEM) image formation. IEEE Transactions on Nuclear Science 2003 50 1 53 59 2-s2.0-0037291606 10.1109/TNS.2002.807942
20. Thompson C. J., Murthy K., Weinberg I. N., Mako F., Feasibility study for positron emission mammography. Medical Physics 1994 21 4 529 538 2-s2.0-0028231817 10.1118/1.597169 (Pubitemid 24129931)
21. Cutler M., Transillumination of the breast. Surgery, Gynecology & Obstetrics 1929 48 721 727
22. Floery D., Helbich T. H., Riedl C. C., Jaromi S., Weber M., Leodolter S., Fuchsjaeger M. H., Characterization of benign and malignant breast lesions with computed tomography laser mammography (CTLM): initial experience. Investigative Radiology 2005 40 6 328 335 2-s2.0-19544378696 10.1097/01.rli.0000164487.60548. 28 (Pubitemid 40734560)
23. Ntziachristos V., Yodh A. G., Schnall M. D., Chance B., MRI-guided diffuse optical spectroscopy of malignant and benign breast lesions. Neoplasia 2002 4 4 347 354 2-s2.0-0036020205 10.1038/sj.neo.7900244 (Pubitemid 34755845)
24. Tromberg B. J., Cerussi A., Shah N., Compton M., Durkin A., Hsiang D., Butler J., Mehta R., Diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy. Breast Cancer Research 2005 7 6 279 285 2-s2.0-29244439606 10.1186/bcr1358 (Pubitemid 41830168)
25. Zhu Q., Cronin E. B., Currier A. A., Vine H. S., Huang M., Chen N., Xu C., Benign versus malignant breast masses: optical differentiation with US-guided optical imaging reconstruction. Radiology 2005 237 1 57 66 2-s2.0-25144478389 10.1148/radiol.2371041236 (Pubitemid 41346146)
26. Leff D. R., Warren O. J., Enfield L. C., Gibson A., Athanasiou T., Patten D. K., Hebden J., Yang G. Z., Darzi A., Diffuse optical imaging of the healthy and diseased breast: a systematic review. Breast Cancer Research and Treatment 2008 108 1 9 22 2-s2.0-42949136616 10.1007/s10549-007-9582-z (Pubitemid 351623242)
27. Poellinger A., Martin J. C., Ponder S. L., Freund T., Hamm B., Bick U., Diekmann F., Near-infrared laser computed tomography of the breast. First clinical experience. Academic Radiology 2008 15 12 1545 1553 2-s2.0-55349147349 10.1016/j.acra.2008.07.023
28. Floery D., Helbich T. H., Riedl C. C., Jaromi S., Weber M., Leodolter S., Fuchsjaeger M. H., Characterization of benign and malignant breast lesions with computed tomography laser mammography (CTLM): initial experience. Investigative Radiology 2005 40 6 328 335 2-s2.0-19544378696 10.1097/01.rli.0000164487.60548. 28 (Pubitemid 40734560)
29. Fournier L. S., Vanel D., Athanasiou A., Gatzemeier W., Masuykov I. V., Padhani A. R., Dromain C., Galetti K., Sigal R., Costa A., Balleyguier C., Dynamic optical breast imaging: a novel technique to detect and characterize tumor vessels. European Journal of Radiology 2009 69 1 43 49 2-s2.0-58249119698 10.1016/j.ejrad.2008.07.038
30. Van De Ven S. M. W. Y., Mincu N., Brunette J., Ma G., Khayat M., Ikeda D. M., Gambhir S. S., Molecular imaging using light-absorbing imaging agents and a clinical optical breast imaging system-a phantom study. Molecular Imaging and Biology 2011 13 2 232 238 2-s2.0-79955936869 10.1007/s11307-010-0356-3
31. Arridge S. R., Schweiger M., Image reconstruction in optical tomography. Philosophical Transactions of the Royal Society B 1997 352 1354 717 726 2-s2.0-0031590041 10.1098/rstb.1997.0054 (Pubitemid 27354103)
32. Schweiger M., Nissilä I., Boas D. A., Arridge S. R., Image reconstruction in optical tomography in the presence of coupling errors. Applied Optics 2007 46 14 2743 2756 2-s2.0-34250726019 10.1364/AO.46.002743 (Pubitemid 46955646)
33. Siegel A. M., Marota J. J. A., Boas D. A., Design and evaluation of a continuous-wave diffuse optical tomography system. Optics Express 1999 4 8 287 298 2-s2.0-0000743021
34. Taroni P., Torricelli A., Spinelli L., Pifferi A., Arpaia F., Danesini G., Cubeddu R., Time-resolved optical mammography between 637 and 985 nm: clinical study on the detection and identification of breast lesions. Physics in Medicine and Biology 2005 50 11 2469 2488 2-s2.0-20044385272 10.1088/0031-9155/50/11/003 (Pubitemid 40770634)
35. Gibson A. P., Hebden J. C., Arridge S. R., Recent advances in diffuse optical imaging. Physics in Medicine and Biology 2005 50 4 R1 R43 2-s2.0-14644412406 10.1088/0031-9155/50/4/R01 (Pubitemid 40309196)
36. Rice A., Quinn C. M., Angiogenesis, thrombospondin, and ductal carcinoma in situ of the breast. Journal of Clinical Pathology 2002 55 8 569 574 2-s2.0-0036342667 10.1136/jcp.55.8.569
37. Vaupel P., Harrison L., Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response. Oncologist 2004 9 5 4 9 2-s2.0-10644270846 (Pubitemid 39658340)
38. Gotz L., Heywang-Kobrunner S. H., Schutz O., Siebold H., Optical mammography on preoperative patients. Aktuelle Radiologie 1998 8 1 31 33 2-s2.0-0031607392 (Pubitemid 28109076)
39. Floery D., Helbich T. H., Riedl C. C., Jaromi S., Weber M., Leodolter S., Fuchsjaeger M. H., Characterization of benign and malignant breast lesions with computed tomography laser mammography (CTLM): initial experience. Investigative Radiology 2005 40 6 328 335 2-s2.0-19544378696 10.1097/01.rli.0000164487.60548. 28 (Pubitemid 40734560)
40. Gu X., Zhang Q., Bartlett M., Schutz L., Fajardo L. L., Jiang H., Differentiation of cysts from solid tumors in the breast with diffuse optical tomography. Academic Radiology 2004 11 1 53 60 2-s2.0-0346102677 10.1016/S1076-6332(03)00562-2 (Pubitemid 38029820)
41. Zhu Q., Cronin E. B., Currier A. A., Vine H. S., Huang M., Chen N., Xu C., Benign versus malignant breast masses: optical differentiation with US-guided optical imaging reconstruction. Radiology 2005 237 1 57 66 2-s2.0-25144478389 10.1148/radiol.2371041236 (Pubitemid 41346146)
42. Bremer C., Ntziachristos V., Weitkamp B., Theilmeier G., Heindel W., Weissleder R., Optical imaging of spontaneous breast tumors using protease sensing 'smart' optical probes. Investigative Radiology 2005 40 6 321 327 2-s2.0-19544391442 10.1097/01.rli.0000163797.23172.90 (Pubitemid 40734559)
43. Bremer C., Tung C. H., Bogdanov A., Weissleder R., Imaging of differential protease expression in breast cancers for detection of aggressive tumor phenotypes. Radiology 2002 222 3 814 818 2-s2.0-0036125256 (Pubitemid 34218157)
44. Hilger I., Leistner Y., Berndt A., Fritsche C., Haas K. M., Kosmehl H., Kaiser W. A., Near-infrared fluorescence imaging of HER-2 protein over-expression in tumour cells. European Radiology 2004 14 6 1124 1129 2-s2.0-2942720684 10.1007/s00330-004-2257-9 (Pubitemid 38787258)
45. Ke S., Wen X., Gurfinkel M., Charnsangavej C., Wallace S., Sevick-Muraca E. M., Li C., Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. Cancer Research 2003 63 22 7870 7875 2-s2.0-0344844469 (Pubitemid 37466721)
46. Ntziachristos V., Yodh A. G., Schnall M., Chance B., Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. Proceedings of the National Academy of Sciences of the United States of America 2000 97 6 2767 2772 2-s2.0-0034646351 10.1073/pnas.040570597 (Pubitemid 30159246)
47. Licha K., Riefke B., Ntziachristos V., Becker A., Chance B., Semmler W., Hydrophilic cyanine dyes as contrast agents for near-infrared tumor imaging: synthesis, photophysical properties and spectroscopic in vivo characterization. Photochemistry and Photobiology 2000 72 392 398
48. Ntziachristos V., Yodh A. G., Schnall M., Chance B., Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. Proceedings of the National Academy of Sciences of the United States of America 2000 97 6 2767 2772 2-s2.0-0034646351 10.1073/pnas.040570597 (Pubitemid 30159246)
49. Corlu A., Choe R., Durduran T., Rosen M. A., Schweiger M., Arridge S. R., Schnall M. D., Yodh A. G., Three-dimensional in vivo fluorescence diffuse optical tomography of breast cancer in humans. Optics Express 2007 15 11 6696 6716 2-s2.0-34249712986 10.1364/OE.15.006696 (Pubitemid 46827669)
50. Achilefu S., Dorshow R. B., Bugaj J. E., Rajagopalan R., Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging. Investigative Radiology 2000 35 8 479 485 2-s2.0-0033853378 10.1097/00004424- 200008000-00004 (Pubitemid 30622015)
51. Weissleder R., Tung C. H., Mahmood U., Bogdanov A., In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nature Biotechnology 1999 17 4 375 378 2-s2.0-0032951071 10.1038/7933 (Pubitemid 29166041)
52. Giambernardi T. A., Grant G. M., Taylor G. P., Hay R. J., Maher V. M., Mccormick J. J., Klebe R. J., Overview of matrix metalloproteinase expression in cultured human cells. Matrix Biology 1998 16 8 483 496 2-s2.0-0031915048 10.1016/S0945-053X(98)90019-1 (Pubitemid 28132527)
53. Frangioni J. V., In vivo near-infrared fluorescence imaging. Current Opinion in Chemical Biology 2003 7 5 626 634 2-s2.0-0142230995 10.1016/j.cbpa.2003.08.007 (Pubitemid 37315800)
54. Tanaka E., Choi H. S., Fujii H., Bawendi M. G., Frangioni J. V., Image-guided oncologic surgery using invisible light: completed pre-clinical development for sentinel lymph node mapping. Annals of Surgical Oncology 2006 13 12 1671 1681 2-s2.0-33845675782 10.1245/s10434-006-9194-6 (Pubitemid 44951476)
55. Knapp D. W., Adams L. G., DeGrand A. M., Niles J. D., Ramos-Vara J. A., Weil A. B., O'Donnell M. A., Lucroy M. D., Frangioni J. V., Sentinel lymph node mapping of invasive urinary bladder cancer in animal models using invisible light. European Urology 2007 52 6 1700 1708 2-s2.0-35748955203 10.1016/j.eururo.2007.07.007 (Pubitemid 350052414)
56. Parungo C. P., Soybel D. I., Colson Y. L., Kim S. W., Ohnishi S., De Grand A. M., Laurence R. G., Soltesz E. G., Chen F. Y., Cohn L. H., Bawendi M. G., Frangioni J. V., Lymphatic drainage of the peritoneal space: a pattern dependent on bowel lymphatics. Annals of Surgical Oncology 2007 14 2 286 298 2-s2.0-33846583341 10.1245/s10434-006-9044-6 (Pubitemid 46175268)
57. Figueiredo J. L., Alencar H., Weissleder R., Mahmood U., Near infrared thoracoscopy of tumoral protease activity for improved detection of peripheral lung cancer. International Journal of Cancer 2006 118 11 2672 2677 2-s2.0-33646356731 10.1002/ijc.21713 (Pubitemid 43673343)
58. Tanaka E., Ohnishi S., Laurence R. G., Choi H. S., Humblet V., Frangioni J. V., Real-time intraoperative ureteral guidance using invisible near-infrared fluorescence. Journal of Urology 2007 178 5 2197 2202 2-s2.0-35148844070 10.1016/j.juro.2007.06.049 (Pubitemid 47538582)
59. Carney P. A., Miglioretti D. L., Yankaskas B. C., Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Annals of Internal Medicine 2003 138 168 175 (Pubitemid 36231622)
60. Boyd N. F., Guo H., Martin L. J., Sun L., Stone J., Fishell E., Jong R. A., Hislop G., Chiarelli A., Minkin S., Yaffe M. J., Mammographic density and the risk and detection of breast cancer. New England Journal of Medicine 2007 356 3 227 236 2-s2.0-33846407655 10.1056/NEJMoa062790 (Pubitemid 46143226)
61. Debbage P., Jaschke W., Molecular imaging with nanoparticles: giant roles for dwarf actors. Histochemistry and Cell Biology 2008 130 5 845 875 2-s2.0-54049117119 10.1007/s00418-008-0511-y